Metabolic Control and Patient Well-being in Phenylketonuria: do Guidelines Make a Difference?

Recruiting

• Conditions: Phenylketonurias

• Registration Number: NCT05128149
• Lead Sponsor: University Children's Hospital, Zurich

Brief Summary

Treatment of PKU implies for most patients that with strict adherence to dietary treatment they can achieve excellent neurocognitive outcome. Dietary treatment, though, is hard to comply to every day and with every single meal. Unsurprisingly, health-related quality of life (HrQol) is negatively affected if patients have to follow a dietary regime of this kind. Adherence to treatment in PKU is very variable. Factors of significant impact on adherence to treatment and well-being in chronic disease such as self-efficacy or parenting stress have not yet been widely investigated in PKU patients.

The ideal treatment prescription (and guideline) recommends as much as necessary and as little as possible, based on the best evidence available. Patients should neither be deprived of treatment options nor be exposed to overtreatment.

This study investigates adherence, metabolic control, HrQol in PKU patients treated by centres which follow different guidelines

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-09-22
• Study First Submitted QC: 2021-11-10
• Study Start: 2021-11-15
• Study First Posted: 2021-11-19
• Primary Completion: 2025-03-30
• Status Verified: 2025-04
• Last Update Submitted: 2025-04-09
• Last Update Posted: 2025-04-13
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Patients with PKU from age 10 years requiring dietary and / or pharmacological treatment according to locally applied guidelines

• Parents of patients with PKU aged 10 to 18 years requiring dietary and / or pharmacological treatment according to locally applied guidelines
• Ability and willingness to answer the questionnaires and follow the study procedures
• Informed consent as documented by signature

Exclusion criteria for patients and parents :

• Inability to follow the procedures of the study, e.g. due to language problems or severely reduced health status
• Pregnant patients or patients who have disclosed to their physician that they are planning a pregnancy in the near future
• Hyperphenylalaninaemia or mild forms of PKU or other inborn errors associated with elevated Phe but not requiring dietary and / or pharmacological treatment according to locally applied guidelines
• No inform

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Phe values	report on measurements from past 24 months	biochemical marker for PKU

Secondary Outcome Measures

Name	Time	Method
Health-related quality of life	one hour	PKU-QoL© Questionnaire
Burden on family (patients from 10-18 years)	one hour	Revised Impact on Family Scale
Self-efficacy	one hour	10 items Self-efficacy scale (Schwarzer\& Jerusalem)

Trial Locations

Locations (1)

University Childrens Hospital Zürich; 🇨🇭 Zürich, Switzerland